| Identification | Back Directory | [Name]
NO-1886 | [CAS]
133208-93-2 | [Synonyms]
OPF 009
NO-1886
ibrolipim
Ibrolipim NO-1886
Lipoprotein Lipase Activator
Diethyl 4-[(4-bromo-2-cyanophenyl)carbamoyl]benzylphosphonate
4-diethoxyphosphorylmethyl-N-(4-bromo-2-cyanophenyl)benzamide
N-(4-bromo-2-cyanophenyl)-4-(diethoxyphosphorylmethyl)benzamide
Diethyl 4-[(4-bromo-2-cyanophenyl)carbamoyl]benzylphosphonate, Ibrolipim, OPF 009
Phosphonic acid, [[4-[[(4-bromo-2-cyanophenyl)amino]carbonyl]phenyl]methyl]-, diethyl ester | [Molecular Formula]
C19H20BrN2O4P | [MDL Number]
MFCD00897807 | [MOL File]
133208-93-2.mol | [Molecular Weight]
451.25 |
| Chemical Properties | Back Directory | [Melting point ]
160.5-162.1 °C | [Boiling point ]
512.5±50.0 °C(Predicted) | [density ]
1.44±0.1 g/cm3(Predicted) | [storage temp. ]
Sealed in dry,2-8°C | [solubility ]
DMSO: ≥20mg/mL | [form ]
powder | [pka]
11.51±0.70(Predicted) | [color ]
off-white to pale yellow |
| Hazard Information | Back Directory | [Uses]
Antiatherogenic; antiobesity;
antidyslipidemia; anticachexia; and antidiabetes/syndrome. | [Biological Activity]
Lipoprotein lipase activator. Overexpression of lipoprotein lipase in transgenic rabbits leads to increased small dense LDL in plasma and promotes atherosclerosis. Long-term administration of NO-1886 protects against the development of experimental atherosclerosis in animals. |
|
| Company Name: |
DC Chemicals
|
| Tel: |
021-58447131 13564518121 |
| Website: |
http://m.is0513.com/ShowSupplierProductsList927327/0.htm |
| Company Name: |
Energy Chemical
|
| Tel: |
021-58432009 400-005-6266 |
| Website: |
http://www.energy-chemical.com |
|